NasdaqGM - Delayed Quote USD

Cronos Group Inc. (CRON)

3.0200 +0.1200 (+4.14%)
At close: May 16 at 4:00 PM EDT
3.0800 +0.06 (+1.99%)
Pre-Market: 9:23 AM EDT
Loading Chart for CRON
DELL
  • Previous Close 2.9000
  • Open 2.8900
  • Bid 2.9900 x 1100
  • Ask 3.0400 x 1500
  • Day's Range 2.8829 - 3.1400
  • 52 Week Range 1.6400 - 3.1400
  • Volume 7,083,322
  • Avg. Volume 3,450,516
  • Market Cap (intraday) 1.163B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1400
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.62

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

www.thecronosgroup.com

356

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

Performance Overview: CRON

Trailing total returns as of 5/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRON
44.50%
S&P/TSX Composite index
6.40%

1-Year Return

CRON
71.59%
S&P/TSX Composite index
8.57%

3-Year Return

CRON
58.57%
S&P/TSX Composite index
15.15%

5-Year Return

CRON
80.07%
S&P/TSX Composite index
36.66%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

Valuation Measures

Annual
As of 5/16/2024
  • Market Cap

    1.16B

  • Enterprise Value

    310.19M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.37

  • Price/Book (mrq)

    1.07

  • Enterprise Value/Revenue

    3.33

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -61.31%

  • Return on Assets (ttm)

    -4.02%

  • Return on Equity (ttm)

    -4.99%

  • Revenue (ttm)

    93.03M

  • Net Income Avi to Common (ttm)

    -54.14M

  • Diluted EPS (ttm)

    -0.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    855.11M

  • Total Debt/Equity (mrq)

    0.21%

  • Levered Free Cash Flow (ttm)

    -37.6M

Research Analysis: CRON

Analyst Price Targets

2.10 Low
2.62 Average
3.0200 Current
3.00
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CRON

Research Reports: CRON

  • Cronos Earnings: Surprising Progress on Narrowing Losses, but Small Size Still a Challenge

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     
  • Cannabis Shares Rally (Again) on Next Incremental Step to Federal Rescheduling

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     
  • First Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     
  • First Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     

People Also Watch